According to Henan Daily reporter on August 7, China's first domestically developd COVID-19 drug approved by the regulator last month and added to the national COVID-19 treatment protocol this week, it's name is Azulfidine tablets, itwas informed that the current price is initially set at less than 300 yuan per bottle, 35 tablets per bottle, 1 mg per tablet.

on July 25, China's State Drug Administration approved the application for registration of Azulfidine tablets for the treatment of New Coronavirus pneumonia by Henan Real Biotechnology Co.ltd.

This means that Azivudine tablets become the first independently developed oral small molecule neo-crown therapeutic drug in China.